Cargando…
Hydrothermal Synthesize of HF-Free MIL-100(Fe) for Isoniazid-Drug Delivery
Sustainable development of drug delivery materials with good biocompatibility and controlled-release is a popular topic among researchers. In this research study, we demonstrated the potential of the metal-organic framework, that is MIL-100(Fe), as a drug delivery platform for isoniazid (INH). The M...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858337/ https://www.ncbi.nlm.nih.gov/pubmed/31729434 http://dx.doi.org/10.1038/s41598-019-53436-3 |
_version_ | 1783470936473731072 |
---|---|
author | Simon, Meta A. Anggraeni, Erlina Soetaredjo, Felycia Edi Santoso, Shella Permasari Irawaty, Wenny Thanh, Truong Chi Hartono, Sandy Budi Yuliana, Maria Ismadji, Suryadi |
author_facet | Simon, Meta A. Anggraeni, Erlina Soetaredjo, Felycia Edi Santoso, Shella Permasari Irawaty, Wenny Thanh, Truong Chi Hartono, Sandy Budi Yuliana, Maria Ismadji, Suryadi |
author_sort | Simon, Meta A. |
collection | PubMed |
description | Sustainable development of drug delivery materials with good biocompatibility and controlled-release is a popular topic among researchers. In this research study, we demonstrated the potential of the metal-organic framework, that is MIL-100(Fe), as a drug delivery platform for isoniazid (INH). The MIL-100(Fe) was prepared by using the hydrofluoric acid-free hydrothermal method. Several physical measurements were conducted to characterize the MIL-100(Fe), including x-ray diffraction (XRD), scanning electron microscopy (SEM), nitrogen sorption, and thermal-gravimetric (TG). The synthesized MIL-100(Fe) has octahedron-shaped particles with superior properties, that is large surface area (1456.10 m(2)/g) and pore volume (1.25 cm(3)/g). The drug loading rate and capacity were determined by means of adsorption kinetic and isotherm. The studied INH@MIL-100(Fe) adsorption system kinetics follow the pseudo-first-order model, while the isotherm system follows the Langmuir model with the maximum adsorption capacity of 128.5 mg/g at 30 °C. MIL-100(Fe) shows adequate biocompatibility, also exhibits a reasonable and controlled drug release kinetics. The results obtained show that MIL-100 (Fe) can be a good choice of drug delivery platform among other available platforms. |
format | Online Article Text |
id | pubmed-6858337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-68583372019-11-27 Hydrothermal Synthesize of HF-Free MIL-100(Fe) for Isoniazid-Drug Delivery Simon, Meta A. Anggraeni, Erlina Soetaredjo, Felycia Edi Santoso, Shella Permasari Irawaty, Wenny Thanh, Truong Chi Hartono, Sandy Budi Yuliana, Maria Ismadji, Suryadi Sci Rep Article Sustainable development of drug delivery materials with good biocompatibility and controlled-release is a popular topic among researchers. In this research study, we demonstrated the potential of the metal-organic framework, that is MIL-100(Fe), as a drug delivery platform for isoniazid (INH). The MIL-100(Fe) was prepared by using the hydrofluoric acid-free hydrothermal method. Several physical measurements were conducted to characterize the MIL-100(Fe), including x-ray diffraction (XRD), scanning electron microscopy (SEM), nitrogen sorption, and thermal-gravimetric (TG). The synthesized MIL-100(Fe) has octahedron-shaped particles with superior properties, that is large surface area (1456.10 m(2)/g) and pore volume (1.25 cm(3)/g). The drug loading rate and capacity were determined by means of adsorption kinetic and isotherm. The studied INH@MIL-100(Fe) adsorption system kinetics follow the pseudo-first-order model, while the isotherm system follows the Langmuir model with the maximum adsorption capacity of 128.5 mg/g at 30 °C. MIL-100(Fe) shows adequate biocompatibility, also exhibits a reasonable and controlled drug release kinetics. The results obtained show that MIL-100 (Fe) can be a good choice of drug delivery platform among other available platforms. Nature Publishing Group UK 2019-11-15 /pmc/articles/PMC6858337/ /pubmed/31729434 http://dx.doi.org/10.1038/s41598-019-53436-3 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Simon, Meta A. Anggraeni, Erlina Soetaredjo, Felycia Edi Santoso, Shella Permasari Irawaty, Wenny Thanh, Truong Chi Hartono, Sandy Budi Yuliana, Maria Ismadji, Suryadi Hydrothermal Synthesize of HF-Free MIL-100(Fe) for Isoniazid-Drug Delivery |
title | Hydrothermal Synthesize of HF-Free MIL-100(Fe) for Isoniazid-Drug Delivery |
title_full | Hydrothermal Synthesize of HF-Free MIL-100(Fe) for Isoniazid-Drug Delivery |
title_fullStr | Hydrothermal Synthesize of HF-Free MIL-100(Fe) for Isoniazid-Drug Delivery |
title_full_unstemmed | Hydrothermal Synthesize of HF-Free MIL-100(Fe) for Isoniazid-Drug Delivery |
title_short | Hydrothermal Synthesize of HF-Free MIL-100(Fe) for Isoniazid-Drug Delivery |
title_sort | hydrothermal synthesize of hf-free mil-100(fe) for isoniazid-drug delivery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858337/ https://www.ncbi.nlm.nih.gov/pubmed/31729434 http://dx.doi.org/10.1038/s41598-019-53436-3 |
work_keys_str_mv | AT simonmetaa hydrothermalsynthesizeofhffreemil100feforisoniaziddrugdelivery AT anggraenierlina hydrothermalsynthesizeofhffreemil100feforisoniaziddrugdelivery AT soetaredjofelyciaedi hydrothermalsynthesizeofhffreemil100feforisoniaziddrugdelivery AT santososhellapermasari hydrothermalsynthesizeofhffreemil100feforisoniaziddrugdelivery AT irawatywenny hydrothermalsynthesizeofhffreemil100feforisoniaziddrugdelivery AT thanhtruongchi hydrothermalsynthesizeofhffreemil100feforisoniaziddrugdelivery AT hartonosandybudi hydrothermalsynthesizeofhffreemil100feforisoniaziddrugdelivery AT yulianamaria hydrothermalsynthesizeofhffreemil100feforisoniaziddrugdelivery AT ismadjisuryadi hydrothermalsynthesizeofhffreemil100feforisoniaziddrugdelivery |